Editas Medicine (EDIT) Tops Q2 EPS by 2c
Editas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Editas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.